Take part in a paid clinical trial

This clinical study is investigating a new oral medication for plaque psoriasis, a chronic autoimmune condition which can lead to raised patches of dry and itchy skin. The purpose of the study is to better understand the safety of the medication, how it is processed by the body, and how the body responds to it. By conducting this study, researchers hope to gain a better understanding of the medication and how it behaves in different populations, which may help support future clinical development and the design of larger studies in people with plaque psoriasis. 

This study is sponsored by a pharmaceutical company.

This clinical study is investigating an investigational vaccine targeting respiratory viruses such as RSV, HMPV and PIV. This investigational vaccine is being developed to address the lack of currently licensed vaccines for prevention of HPMV and PIV. Researchers are evaluating this investigational vaccine to better understand its safety, tolerability and how the body responds to it. 

By conducting this study, researchers hope to gain a better understanding of the medication and how it behaves in different populations, which may help support future clinical development and the design of subsequent research studies to help with protection from respiratory viruses. 

This study is sponsored by a pharmaceutical company.

Autoimmune diseases happen when the body mistakenly produces harmful antibodies that attack its own organs and tissues. There are around 100 of these diseases, affecting about 240 million people globally. Although some treatments exist, there’s still a big need for better, targeted options, especially ones that are easy to take, like oral medications.

Most advanced treatments today are given through IV or under the skin. These methods can be inconvenient and affect a patient’s quality of life. That’s why an oral treatment like the study drug could be a game-changer, making treatment easier and more appealing, especially for people who prefer to avoid needles. This study aims to create more effective and accessible potential medication for millions of people across the globe.

This study is looking at an investigational oral drug for people living with obesity or overweight. 

Obesity is a chronic disease that is estimated to affect ~880 million adults globally.  Adults living with obesity and overweight are at higher risk for other health problems. For some people, medicines are recommended to support weight management; however, more treatment options are needed to treat this chronic disease.  The investigational drug is an oral tablet that is designed to help people feel full sooner and reduce feelings of hunger, which may help people eat less over time. 

The start date for this study is flexible. If you pass the initial screening, the study coordinator will work with you to schedule your exact dates.
Please note that you can only be admitted between Sunday and Thursday.